A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke
Clinical trial NCT06299033 · UNKNOWN
Trial details
- NCT number
- NCT06299033
- Sponsor
- Hopstem Biotechnology Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2024-08-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.